BASA Basanite Inc (QB)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————

FORM 10-Q

———————

 (Mark One)

 

☒  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: March 31, 2024

 

or

 

¨  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from: _____________ to _____________

 

Commission File Number: 000-53574

———————

Basanite, Inc.

(Exact name of registrant as specified in its charter)

———————

Nevada	20-4959207
(State or other jurisdiction	(I.R.S. Employer
of incorporation or organization)	Identification No.)

 

2660 NW 15th Court, Unit 108, Pompano Beach, Florida 33069

(Address of Principal Executive Office) (Zip Code)

 

(954) 532-4653

(Registrant’s telephone number, including area code)

 

_______________________________________________

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

———————

Securities registered pursuant to Section 12(b) of the Act: None.

  

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes   ¨ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  ☒ Yes  ¨ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨		Accelerated filer   ¨
Non-accelerated filer     ☒		Smaller reporting company  ☒
		Emerging growth company  ¨

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes  ☒ No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

 

Class		Shares Outstanding as of May 17, 2024
Common Stock, $0.001 par value per share		260,156,796

 

BASANITE, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

 

		Page No.
	PART I. – FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements
	Condensed Consolidated Balance Sheets as of March 31, 2024 (Unaudited) and December 31, 2023	1
	Condensed Consolidated Statements of Operations (Unaudited) for the Three Months Ended March 31, 2024 and 2023	2
	Condensed Consolidated Statements of Stockholder’s (Deficit) Equity (Unaudited) for Three Months Ended March 31, 2024 and 2023	3
	Condensed Consolidated Statements of Cash Flows (Unaudited) for the Three Months Ended March 31, 2024 and 2023	5
	Notes to Condensed Consolidated Financial Statements (Unaudited)	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	19
Item 4.	Controls and Procedures	19
	PART II. – OTHER INFORMATION
Item 1.	Legal Proceedings	20
Item 1A.	Risk Factors	20
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 3.	Defaults Upon Senior Securities	20
Item 4.	Mine Safety Disclosures	20
Item 5.	Other Information	20
Item 6.	Exhibits	20
Signatures		21

 

 

 

 

 

 

 

 

PART I. – FINANCIAL INFORMATION

 

ITEM 1.

FINANCIAL STATEMENTS

 

BASANITE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

		March 31,				December 31,
		2024				2023
ASSETS
CURRENT ASSETS
Cash		$	3,791			$	55,248
Accounts receivable, net			36,391				40,222
TOTAL CURRENT ASSETS			40,182				95,470
Lease right-of-use asset, operating			32,759				56,915
Fixed assets, net			370,309				402,271
TOTAL NON–CURRENT ASSETS			403,068				459,186
TOTAL ASSETS		$	443,250			$	554,656
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable		$	1,789,184			$	1,762,390
Accrued expenses			1,288,459				1,207,545
Due to shareholders			475,000				475,000
Notes payable			270,000				270,000
Notes payable - related party			1,828,000				1,750,000
Notes payable - convertible - related party, net			2,144,357				2,144,357
Lease liability - current portion			32,759				56,915
TOTAL CURRENT LIABILITIES			7,827,759				7,666,207
TOTAL LIABILITIES			7,827,759				7,666,207
STOCKHOLDERS’ (DEFICIT) EQUITY
Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding			—				—
Common stock, $0.001 par value, 1,000,000,000 shares authorized, 260,156,796 and 259,156,796 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively			260,157				259,157
Additional paid-in capital			48,905,681				48,891,681
Accumulated deficit			(56,550,347	)			(56,262,389	)
TOTAL STOCKHOLDERS’ (DEFICIT) EQUITY			(7,384,509	)			(7,111,551	)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY		$	443,250			$	554,656

  

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

BASANITE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED) 

 

 

		For the three months ended
		March 31,
		2024				2023
Revenue
Products sales		$	59,449			$	115,118
Total cost of goods sold			4,259				19,751
Gross (loss) profit			55,191				95,367
OPERATING EXPENSES
Sales, general, and administrative			154,329				434,784
Total operating expenses			154,329				434,784
NET LOSS FROM OPERATIONS			(99,139	)			(339,417	)
OTHER INCOME (EXPENSE)
Interest expense			(188,819	)			(129,037	)
Total other income (expense)			(188,819	)			(129,037	)
NET LOSS		$	(287,958	)		$	(468,454	)
Net loss per share –
Basic		$	(0.00	)		$	(0.00	)
Diluted		$	(0.00	)		$	(0.00	)
Weighted average number of shares outstanding –
Basic			259,690,129				253,217,402
Diluted			259,690,129				253,217,402

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

BASANITE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

(UNAUDITED)

 

																										Total
																		Additional								Stockholders'
		Preferred Stock								Common Stock								Paid-in				Accumulated				(Deficit)
		Shares				Par Value				Shares				Par Value				Capital				Deficit				Equity
Balance January 1, 2024			—			$	—				259,156,796			$	259,157			$	48,891,681			$	(56,262,389	)		$	(7,111,551	)
Stock-based compensation			—				—				1,000,000				1,000				14,000				—				15,000
Net loss			—				—				—				—				—				(287,958	)			(287,958	)
Balance March 31, 2024			—			$	—				260,156,796			$	260,157			$	48,905,681			$	(56,550,347	)		$	(7,384,509	)

 

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

 

 

 

BASANITE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (CONTINUED)

FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

(UNAUDITED)

 

																		Additional								Total
		Preferred Stock								Common Stock								Paid-in				Accumulated				Stockholders'
		Shares				Par Value				Shares				Par Value				Capital				Deficit				Deficit
Balance January 1, 2023			—			$	—				253,217,402			$	253,218			$	47,433,354			$	(52,642,392	)		$	(6,406,438	)
Stock based compensation			—				—				—				—				64,266				—				—
Net loss			—				—				—				—				—				(468,454	)			(2,299,422	)
Balance March 31, 2023			—			$	—				253,217,402			$	253,218			$	47,497,620			$	(54,561,464	)		$	(6,810,626	)

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

BASANITE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

		For the three months ended
		March 31,
		2024				2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss		$	(287,958	)		$	(468,454	)
Adjustments to reconcile net loss to net cash used in operating activities:
Lease right-of-use asset amortization			24,156				25,981
Depreciation			31,962				32,064
Stock-based compensation			15,000				64,226
Changes in operating assets and liabilities:
Prepaid expenses			—				26,336
Accounts receivable			3,831				(242	)
Accounts payable and accrued expenses			107,708				258,009
Subscription liability			—				—
Lease liability			(24,156	)			(22,812	)
Net cash used in operating activities			(129,457	)			(84,852	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities			—				—
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock, net			—				—
Proceeds from exercise of stock options			—				—
Proceeds from notes payable and notes payable related party			78,000				90,000
Repayments of notes payable and notes payable related party			—				(4,785	)
Net cash provided by financing activities			78,000				85,215
NET INCREASE IN CASH			(51,457	)			363
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD			55,248				30,340
CASH AND CASH EQUIVALENTS AT END OF PERIOD		$	3,791			$	30,703
Supplemental cash flow information:
Cash paid for interest		$	—			$	—
Cash paid for taxes		$	—			$	—

 

 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

 

BASANITE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN

 

(A) Description of Business

 

Basanite, Inc., a Nevada corporation (the “Company”, “Basanite”, “we”, “us”, “our” or similar terminology), through our wholly owned subsidiary, Basanite Industries, LLC, a Delaware limited liability company (“BI”), manufactures a range of “green” (environmentally friendly), sustainable, non-corrosive, lightweight, composite products used in concrete reinforcement by the construction industry. Our core product is BasaFlex™, a basalt fiber reinforced polymer reinforcing bar (“rebar”) which we believe is a stronger, lighter, sustainable, non-conductive and corrosion-proof alternative to traditional steel.

 

Our two other main product lines are BasaMix™, which are fine denier basalt fibers available in various sizes, and BasaMesh™, a line of Basalt Geogrid Mesh Rolls, intended to replace welded wire mesh (made of steel) and other fiber reinforced polymer (“FRB”) grids and mesh.

 

BasaMix™ is designed to help absorb the stresses associated with early-aged plastic shrinkage and settlement cracking in concrete, as well as providing an increased toughness for enhanced reinforcement in Slab-on-Grade ("SOG”) and precast elements. BasaMix™ also serves in a “system approach” for optimum performance of a concrete element when used in conjunction with our BasaFlex™ rebar.

 

BasaMesh™ is designed for secondary and temperature shrinkage reinforcement. BasaMesh™ can also work in conjunction with the BasaFlex™ rebar or BasaMix™ for a total reinforcement program.

 

Each of our products is specifically designed to extend the lifecycle of concrete products by eliminating “concrete spalling.” Spalling results from the steel reinforcing materials embedded within the concrete member rusting (contrary to popular belief, concrete is porous and water can permeate into concrete). Rusting leads to the steel expanding and eventually causing the surrounding concrete to delaminate, crack, or even break off, resulting in potential structural failure. We believe that each Basanite product addresses this important need along with other key requirements in today’s construction market.

 

(B) Liquidity and Management Plans

 

Since inception, the Company has incurred net operating losses and used cash in operations. As of March 31, 2024, and December 31, 2023, respectively, the Company reported:

 

•

an accumulated deficit of $56.6 million and $56.3 million;

 

•

a working capital deficiency of $7.8 million and $7.6 million; and

 

•

cash used in operations of $129.4 thousand

 

Losses have principally occurred as a result of the substantial resources required for product research and development and for marketing of the Company’s products; including the general and administrative expenses associated with the organization.

 

While we have generated relatively little revenue to date, revenue from sales of product began to increase in the quarter ended March 31, 2021, and we continue to receive inquiries and solicit orders from a range of customers for our products, indicating what we believe is a significant level of market interest for BasaFlex™. While the Company expects to expand its manufacturing capacity during 2025, based on our current limited manufacturing capacity there is no guarantee that orders will actually be received or that orders, if received, can be properly fulfilled.

 

 

6

BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (CONTINUED)

 

We have historically satisfied our working capital requirements through the sale of restricted common stock of the Company, $0.001 par value per share (the “Common Stock”), and the issuance of warrants to purchase Common Stock and promissory notes. Until we are able to internally generate meaningful revenue and positive cash flow, we will attempt to fund working capital requirements through third party financing, including through potential private or public offerings of our securities as well as bridge or other loan arrangements. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. We cannot provide any assurances that the required capital will be obtained at all, or that the terms of such required capital may be acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results of operations may suffer, and our business may fail.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

(A) Use of Estimates in Financial Statements

 

The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is typically estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying Common Stock, the expected term of the option, the expected volatility of the price of our Common Stock, risk-free interest rates and the expected dividend yield of our Common Stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.

 

The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the three months ended March 31, 2024 and 2023, respectively:

 

Schedule of fair value assumptions of warrants and options issued
		Three months				Three months
		ended				ended
		March 31,				March 31,
		2023				2022
Expected price volatility			—				176.23	%
Risk-free interest rate			—				5.63
Expected life in years			—				5
Dividend yield			—				—

 

(B) Principles of Consolidation

 

The condensed consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC. All intercompany balances have been eliminated in consolidation. The Company’s operations are conducted primarily through Basanite Industries, LLC. Basalt America, LLC is currently inactive.

 

 

7

BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(C) Cash

 

The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company “("FDIC") up to $250,000. The Company’s credit risk in the event of failure of these financial institutions is represented by the difference between the FDIC limit and the total amounts on deposit. Management monitors the financial institutions credit worthiness in conjunction with balances on deposit to minimize risk. The Company from time to time may have amounts on deposit in excess of the insured limits.

 

(D) Inventories

 

The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at lower of cost or net realizable value. Cost is determined on the first-in, first-out basis. Raw materials inventory consists of basalt fiber and other necessary elements to produce the basalt rebar. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value. The Company had no inventory as of March 31, 2024 and December 31, 2023.

 

(E) Fixed assets

 

Fixed assets consist of the following:

 

Schedule of fixed assets
		March 31,				December 31,
		2024				2023
		(Unaudited)
Computer equipment		$	224,473			$	224,473
Machinery			728,245				728,245
Construction in process			—				—
			931,438				931,438
Accumulated depreciation			(561,129	)			(529,168	)
		$	370,309			$	402,270

 

Depreciation expense for the three months ended March 31, 2024 was $31,962 compared to $32,064 for the three months ended March 31, 2023.

 

(F) Deposits and other current assets

 

The Company’s deposits and other current assets consist of the deposits made on equipment, security deposits, utility deposits and other receivables. The deposits are reclassified as part of the fixed asset cost when received and placed into service.

 

(G) Loss Per Share

 

The basic loss per share is calculated by dividing the Company's net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company's net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.

 

The following are potentially dilutive shares not included in the loss per share computation:

 

Schedule of dilutive shares not included in the loss per share computation
		March 31,				December 31,
		2024				2023
		(Unaudited)
Options			1,277,778				1,477,778
Warrants			129,699,090				125,295,757
Convertible securities			8,016,068				8,016,068
Total			138,992,936				134,789,603

 

(H) Stock-Based Compensation

 

The Company recognizes compensation costs to employees under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant. The Company recognized $0 in stock-based compensation during the three months ended March 31, 2024.

 

 

8

BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

 

(I) Revenue Recognition

 

We recognize revenue when control of the promised goods or services is transferred to the Company’s customers in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. The timing of revenue recognition largely is dependent on shipping terms. Revenue is recorded at the time of shipment for terms designated free on board (“FOB”) shipping point. For sales transactions designated FOB destination, revenue is recorded when the product is delivered to the customer’s delivery site.

 

All revenues recognized are net of trade allowances, cash discounts, and sales returns. Trade allowances are based on the estimated obligations. Adjustments to earnings resulting from revisions to estimates on discounts and returns have been immaterial for each of the reported periods. Shipping and handling amounts billed to a customer as part of a sales transaction are included in revenues, and the related costs are included in cost of goods sold. Shipping and handling is treated as a fulfillment activity, rather than a promised service, and therefore is not considered a separate performance obligation. During the three months ended March 31, 2023 and 2022, the Company incurred shipping and handling costs in the amount of $6,340 and $8,355, respectively.

 

NOTE 3 – OPERATING LEASE

 

On January 18, 2019, the Company entered into an agreement to lease approximately 25,470 square feet of office and manufacturing space in Pompano Beach, Florida through March 2024. On March 25, 2019, the Company entered into an amendment to the agreement to increase the square footage of leased premises to 36,900 square feet, increasing the Company’s base rent obligation to be approximately $33,825 per month for one year and nine months, and increasing annually at a rate of three percent for the remainder of the lease term.

 

On December 31, 2022 the Company vacated the lease, as of this filing the Company has not entered into a new commercial lease for a manufacturing facility. The Company is actively engaged in a nation-wide search to secure a manufacturing facility.

 

For the three months ended March 31, 2024 and 2023, the Company expensed $0, respectively for rent.

 

NOTE 4 – NOTES PAYABLE

 

Notes payable totaled $270,000 and $299,458 for March 31, 2024, and December 31, 2023, respectively.

 

On April 2, 2021, the Company issued a promissory note with an investor in exchange for $200,000 bearing an interest rate of 18% per annum and payable on October 2, 2022. The Company also issued a warrant to purchase 2,000,000 shares of Common Stock at an exercise price of $0.20 per share expiring in 5 years. The note was not paid by its due date. As of the date of this filing, the noteholder has not issued a formal demand for payment and the Company is in negotiations with the noteholder to remedy the past-due status.

 

On April 9, 2021, the Company issued a promissory note with an investor in exchange for $50,000 bearing an interest rate of 18% per annum and payable on October 9, 2022. The Company also issued a warrant to purchase 500,000 shares of Common Stock at an exercise price of $0.20 per share expiring in 5 years. The note was not paid by its due date. As of the date of this filing, the noteholder has not issued a formal demand for payment and the Company is in negotiations with the noteholder to remedy the past-due status.

 

On April 16, 2021, the Company issued a promissory note with an investor in exchange for $25,000 bearing an interest rate of 18% per annum and payable on October 16, 2022. The Company also issued a warrant to purchase 250,000 shares of Common Stock at an exercise price of $0.25 per share expiring in 5 years. The note was not paid by its due date. As of the date of this filing, the noteholder has not issued a formal demand for payment and the Company is in negotiations with the noteholder to remedy the past-due status.

 

During the three months ended March 31, 2024, the Company made principal payments in the amount of $0 on notes payable.

 

Interest expense for the Company’s notes payable for the three months ended March 31, 2024 was $17,034 compared to $17,051 for the three months ended March 31, 2023.

 

Accrued interest for the Company’s notes payable on March 31, 2024 and December 31, 2023 was $176,664 and $159,630, respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

 

NOTE 5 – NOTES PAYABLE – RELATED PARTY

 

Notes payable - related party totaled $1,828,000 March 31, 2024 and $1,750,000 December 31, 2023, respectively.

 

On January 16, 2020, the Company entered into a demand note agreement with our Board Chairman, Michael V. Barbera, in the amount of $50,000. The note has a term of 6 months bearing an interest rate of 10% per annum. On April 13, 2020, an addendum was executed changing the terms of the note to a convertible note payable bearing an interest rate of 12% per annum. Per the addendum, the principal and accrued interest is convertible at the option of the holder after June 5, 2020 at a 20% discount of that days’ closing price. See Note 6 for information regarding this convertible note payable – related party.

 

On April 2, 2021, the Company issued a promissory note with Paul Sallarulo, a member of our Board of Directors, in exchange for $150,000 bearing an interest rate of 18% per annum and payable on October 2, 2022. The company also issued 1,500,000 common stock warrants at an exercise price of $0.20 per share expiring in 5 years. The note was not paid by its due date. On April 2, 2022, the due date of this note was extended to April 1, 2024. As of the date of this report, the note has not been called.

 

9

BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 5 – NOTES PAYABLE – RELATED PARTY (CONTINUED)

 

On April 2, 2021, the Company issued a promissory note with Michael V. Barbera, our Chairman of the Board, in exchange for $150,000 bearing an interest rate of 18% per annum and payable on October 2, 2022. The company also issued 1,500,000 common stock warrants at an exercise price of $0.20 per share expiring in 5 years. The note was not paid by its due date. On April 2, 2022, the due date of this note was extended to April 1, 2024. As of the date of this report, the note has not been called.

 

On August 31, 2022 the Company issued a promissory note to a board member in exchange for $37,000 bearing an interest rate of 10% per annum and payable on August 31, 2024.

 

On August 22, 2022 the Company issued a promissory note to a board member in exchange for $20,000 bearing an interest rate of 10% per annum and payable on August 22, 2024.

 

On August 22, 2022 the Company issued a promissory note to a board member in exchange for $5,000 bearing an interest rate of 10% per annum and payable on August 22, 2024.

 

On August 29, 2022 the Company issued a promissory note to a board member in exchange for $25,000 bearing an interest rate of 10% per annum and payable on August 29, 2024.

 

On August 29, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on August 29, 2024.

 

On August 31, 2022 the Company issued a promissory note to a board member in exchange for $13,000 bearing an interest rate of 10% per annum and payable on August 31, 2024.

 

On September 9, 2022 the Company issued a promissory note to a board member in exchange for $60,000 bearing an interest rate of 10% per annum and payable on August 16, 2024.

 

On September 9, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on September 9, 2024.

 

On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $10,000 bearing an interest rate of 10% per annum and payable on September 9, 2024.

 

On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $15,000 bearing an interest rate of 10% per annum and payable on September 9, 2024.

 

On September 9, 2022 the Company issued a promissory note to an investor and advisor to the board, in exchange for $15,000 bearing an interest rate of 10% per annum and payable on September 9, 2024.

 

On September 22, 2022 the Company issued a promissory note to a board member in exchange for $42,500 bearing an interest rate of 18% per annum and payable on September 22, 2024.

 

On February 14, 2023 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 20% per annum and payable on February 13, 2024.

 

On February 24, 2023 the Company issued a promissory note to a board member in exchange for $50,000 bearing an interest rate of 20% per annum and payable on February 23, 2024.

 

On March 3, 2023 the Company issued a promissory note to a board member in exchange for $15,000 bearing an interest rate of 20% per annum and payable on March 2, 2024.

 

On March 24, 2023 the Company issued a promissory note to a board member in exchange for $15,000 bearing an interest rate of 20% per annum and payable on March 23, 2024.

 

On April 12, 2023 the Company issued a promissory note to a board member in exchange for $150,000 bearing an interest rate of 20% per annum and payable on April 11, 2024.

 

On April 28, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable on April 27, 2024.

 

On May 12, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable on May 11, 2024.

 

10

BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 5 – NOTES PAYABLE – RELATED PARTY (CONTINUED)

 

On June 5, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable on June 4, 2024.

 

On July 25, 2023 the Company issued a promissory note to a board member in exchange for $200,000 bearing an interest rate of 20% per annum and payable on July 24, 2024.

 

On September 11, 2023 the Company issued a promissory note to a board member in exchange for $150,000 bearing an interest rate of 20% per annum and payable on September 10, 2024.

 

On September 11, 2023 the Company issued a promissory note to an advisor to the board in exchange for $50,000 bearing an interest rate of 20% per annum and payable on September 10, 2024.

 

On November 2, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable on November 1, 2024.

 

On December 12, 2023 the Company issued a promissory note to a board member in exchange for $75,000 bearing an interest rate of 20% per annum and payable on December 11, 2024.

 

On January 9, 2024 the Company issued a promissory note to a board member in exchange for $23,000 bearing an interest rate of 20% per annum and payable on January 8, 2025.

 

On March 6, 2024 the Company issued a promissory note to a board member in exchange for $40,000 bearing an interest rate of 20% per annum and payable on March 5, 2025.

 

On March 21, 2024 the Company issued a promissory note to a board member in exchange for $15,000 bearing an interest rate of 20% per annum and payable on March 20, 2025.

 

Interest expense for the Company’s notes payable – related party for the three months ended March 31, 2024 and 2023 was $25,750 and $23,599, respectively.

 

Accrued interest for the Company’s notes payable - related party on March 31, 2023, and December 31, 2023, was $1,213,507 and $996,963, respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

 

NOTE 6 – NOTES PAYABLE – CONVERTIBLE – RELATED PARTY

 

Convertible Notes payable – related party totaled $2,144,357 on March 31, 2024, and December 31, 2023.

 

On August 3, 2020, the Company issued a secured convertible promissory note to certain investors in exchange for $ 1,000,000 in the aggregate bearing an interest rate of 20% per annum and payable in 6 months. The holder may convert the unpaid principal balance of the note into shares of restricted Common Stock at the conversion price equal to $0.275 per share, which conversion price was set with the consummation of the Company’s private placement of Units which closed on August 17, 2021. This note contains a negative covenant that requires the Company to obtain consent prior to incurring any additional equity or debt investments and is secured by all of the assets of the Company. The Richard A. LoRicco Sr. and Lucille M. LoRicco Irrevocable Insurance Trust DTD 4/28/95, Louis Demaio as Trustee (the “Trust”) is the holder of $ 750,000 of the principal amount of this note. The Trust was created by Richard A. LoRicco Sr. and Lucille M. LoRicco, who were the parents of Ronald J. LoRicco Sr., one of the members of the Company’s Board of Directors and is maintained by an independent trustee. Ronald J. LoRicco Sr. does not have voting or investment control of or power over the Trust but is an anticipated, partial beneficiary of the Trust.

 

On February 12, 2021, the Company exchanged the original debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $1,610,005 bearing an interest rate of 20% per annum and fully payable in 3 months. This was accounted for as a debt extinguishment and the new promissory note was recorded at fair value in accordance with ASC 470 “Debt”. The original principal of $1,000,000 and accrued interest of $110,005 calculated as of the date of amendment and restatement along with an additional advance of $500,000 determined the principal amount of the new note. In consideration of the additional advance and the extension of the maturity date of the original note, the Company issued to the noteholders 5-year warrants to purchase an aggregate of 15,000,000 shares of Common Stock with an exercise price of $0.20 per share. The issuance of the warrants for the extension generated a loss on extinguishment of $3,686,123 for the fair value of the warrants issued.

 

11

BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 6 – NOTES PAYABLE – CONVERTIBLE – RELATED PARTY (CONTINUED)

 

On May 12, 2021, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $1,689,746 bearing an interest rate of 20% per annum and fully payable February 12, 2022. The original principal of $1,610,005 and accrued interest of $79,742 calculated as of the date of amendment and restatement determined the principal amount of the new note. In consideration of the additional advance and the extension of the maturity date of the original note, the Company issued to the noteholders 5-year warrants to purchase an aggregate of 7,500,000 shares of common stock with an exercise price of $0.35 per share. The issuance of the warrants for the extension generated a loss on extinguishment of $1,874,705 for the fair value of the warrants issued. The note was not paid by its due date of February 12, 2022. As of the date of this filing, the noteholder has not issued a formal demand for payment and the Company is in negotiations with the noteholder to remedy the past-due status.

 

On September 15, 2022, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $2,027,695 bearing an interest rate of 20% per annum and fully payable February 12, 2023. The amended principal of $1,689,746 and accrued interest of $454,612 calculated as of the date of amendment and restatement determined the principal amount of the new note. No additional consideration was provided.

 

Interest expense for the Company’s convertible notes payable – related parties for the three months ended March 31, 2024, was $107,218 and for the three months ended March 31, 2023, respectively.

 

Accrued interest for the Company’s convertible notes payable – related parties on March 31, 2024 and December 31, 2023, was $665,430 and $558,212, respectively, and is included in accrued expenses on the condensed consolidated balance sheets.

 

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

The Company is the obligor under certain promissory notes that are currently past due (although formal events of default have not been declared).

 

See notes 4 and 5.

 

The Company is presently in default of its obligations under the terms of the Company’s private placement which closed in August 2021 to file a registration statement for an underwritten public offering and concurrently listing on a national stock exchange. As a result, the Company is required to pay liquidated damages in the amount of $53,345 per month starting in March 2022, and the maximum amount of such liquidated damages could be approximately $480,000 if such filing is not made.

 

On August 17, 2021, the Company conducted the closing of a private placement offering to accredited investors of the Company’s units at a price of $0.275 per unit, with each unit consisting of: (i) one share of the Company’s common stock, (ii) a five-year, immediately exercisable warrant (“Warrant A”) to purchase one share of common stock at an exercise price of $0.33 per share and (iii) an additional five-year, immediately exercisable warrant to purchase one share of common stock at an exercise price of $0.33 per share (“Warrant B”). The Warrant A and Warrant B are identical, except that the Warrant B has a call feature in favor of the Company, as defined in the offering agreements. In connection with the closing, the Company entered into definitive securities purchase agreements with 19 accredited investors and issued an aggregate of 19,398,144 shares of common stock, Warrant A to purchase up to an aggregate of 19,398,144 shares of common stock, and Warrant B to purchase up to an aggregate of 19,398,144 shares of Common Stock (for an aggregate of 38,796,288 Warrant Shares), for aggregate gross proceeds to the Company of approximately $5,334,490. Costs of the offering in the amount of $611,603 were charge to additional paid in capital. As of December 31, 2022 the Company also accrued the amount of $386,759 as liquidated damages due to the investors in the Company’s August 2021 private placement, such liquidated damages being related to the Company’s failure to timely file a registration statement on Form S-1 for an underwritten public offering and concurrent listing of the Common Stock on a national exchange.

 

NOTE 8 – STOCKHOLDERS’ DEFICIT

 

During the three months ended March 31, 2024, the Company issued 1,000,000 shares of common stock to our former CEO. The shares were valued at the closing stock price on the date of grant for a total value of $15,000 recorded in stock-based compensation.

 

12

BASANITE, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 9 – OPTIONS AND WARRANTS

 

Stock Options:

 

The following table provides the activity in options for the respective periods:

 

Schedule of option activity
		Total Options				Weighted Average				Aggregate Intrinsic
		Outstanding				Exercise Price				Value
Balance at January 1, 2023			1,477,778				0.27			$	—
Issued			—				0.27				—
Cancelled / Expired			—				0.27				—
Balance at December 31, 2023			1,477,778			$	0.27			$	—
Exercised			—				0.27				—
Cancelled / Expired			(2,000,000	)			0.27				—
Balance at March 31, 2024			1,277,778			$	0.27			$	—

 

Options exercisable and outstanding at March 31, 2023 are as follows:

Schedule of options exercisable and outstanding
Range of Exercise Prices		Number Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Aggregate Intrinsic Value
$0.01 - $0.50		1,277,778		2.14		$0.27		—

 

See note 8.

 

Stock Warrants:

 

The following table provides the activity in warrants for the respective periods:

 

Schedule of warrants activity
		Total				Weighted Average				Aggregate Intrinsic
		Warrants				Exercise Price				Value
Balance at January 1, 2023			139,555,757			$	0.29			$	150,667
Granted			2,000,000				0.29				—
Exercised			—				0.29				—
Cancelled			(16,260,000	)
Balance at December 31, 2023			125,295,757			$	0.29			$	135,272
Granted			4,403,333				0.29				—
Balance at March 31, 2024			129,699,090			$	0.29			$	—

 

Warrants exercisable and outstanding at March 31, 2023 are as follows:

Schedule of warrants exercisable and outstanding
Range of Exercise Prices		Number Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Aggregate Intrinsic Value
$0.01 - $0.50		129,699,090		2.07		$0.29		$—
$0.51 - $1.00		—		0.85		$0.60		—
		129,699,090						$150,667

 

NOTE 10 – SUBSEQUENT EVENTS

 

None.

   

 

 

 

 

 

ITEM 2.

MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

  

This overview provides a high-level discussion of our operating results and some of the trends that affect our business. We believe that an understanding of these trends is important to understand our financial results for the three months ended March 31, 2024 and 2023, respectively. This summary is not intended to be exhaustive, nor is it intended to be a substitute for the detailed discussion and analysis provided elsewhere in this report, and our audited consolidated financial statements and accompanying notes included in the Annual Report in Form-10-K for the period ended December 31, 2032 and filed with the SEC on April 15, 2024.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These forward-looking statements are based on our management’s beliefs, assumptions, and expectations and on information currently available to our management. Generally, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “predicts,” “potential” and similar expressions intended to identify forward-looking statements, which generally are not historical in nature. All statements that address operating or financial performance, events, or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations with respect to the timing for our planned manufacturing expansion, the benefits of our products, customer leads, product sales, financings, or the commercial viability of, and prospects for, our business model. We may not actually achieve the plans, projections or expectations disclosed in forward-looking statements, and actual results, developments or events (including, without limitation, those related to our planned manufacturing capacity expansion and our sales and marketing initiatives) could differ materially from those disclosed in the forward-looking statements. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. We do not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by federal securities laws and the rules of the Securities and Exchange Commission (the “SEC”). We may not actually achieve the plans, projections or expectations disclosed in our forward-looking statements, and actual results, developments or events could differ materially and adversely from those disclosed in the forward-looking statements. Forward-looking statements are subject to a number of significant risks and uncertainties, including without limitation those described from time to time in our reports filed with the SEC.

 

The following discussion and analysis of our financial condition and results of operations should be read together with our unaudited interim condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q as well as the risk factors and other disclosures contained in our Annual Report on Form 10-K for the period ended December 31, 2023.

 

Basanite, Inc., and its wholly owned subsidiaries are referred to in this discussion as the “Company”, “we”, “our”, or “us”. “Common stock” refers to the common stock of the Company.

 

Overview

 

On May 30, 2006, Basanite, Inc. was formed as a Nevada corporation. Through our wholly owned subsidiary, Basanite Industries, LLC, a Delaware limited liability company (“BI”), we manufacture a range of “green” (environmentally friendly), sustainable, non-corrosive, lightweight, composite products used in concrete reinforcement by the construction industry. Our core product is BasaFlex™, a basalt fiber reinforced polymer reinforcing bar (“rebar”) which we believe is a stronger, lighter, sustainable, non-conductive and corrosion-proof alternative to traditional steel.

 

Our two other main product lines are BasaMix™, which are fine denier basalt fibers available in various chopped sizes, and BasaMesh™, a line of Basalt Geogrid Mesh Rolls, intended to replace welded wire mesh (made of steel) and other fiber reinforced polymer grids and mesh.

 

BasaMix™ is designed to help absorb the stresses associated with early-aged plastic shrinkage and settlement cracking in concrete, as well as providing an increased toughness for enhanced reinforcement in Slab on Grade (SOG) and precast elements. BasaMix™ also serves in a “system approach” for optimum performance of a concrete element when used in conjunction with our BasaFlex™ rebar.

 

BasaMesh™ is designed for secondary and temperature shrinkage reinforcement. BasaMesh™ can also work in conjunction with the BasaFlex™ rebar or BasaMix™ for a total reinforcement program.

 

Each of our products is specifically designed to extend the lifecycle of concrete products by eliminating “concrete spalling.” Spalling results from the steel reinforcing materials embedded within the concrete member rusting (contrary to popular belief, concrete is porous, and water can permeate into concrete). Rusting leads to the steel expanding and eventually causing the surrounding concrete to delaminate, crack, or even break off, resulting in potential structural failure. We believe that each of our products addresses this important need along with other key requirements in today’s construction market.

 

 

We believe that the following attributes of BasaFlex™ provide it with a competitive advantage in the marketplace:

 

•

BasaFlex™ never corrodes: steel reinforcement products rust, leading to spalling and significant repair costs down the road;

 

•

BasaFlex™ is sustainable: BasaFlex™ is made from Basalt rock, the most abundant rock found on Earth’s surface, and offers a longer product lifecycle than traditional steel (the lack of corrosion allows the life span of concrete products reinforced with BasaFlex to be significantly longer);

 

•

BasaFlex™ is “green”: From mining, through production, to installation at the building site, BasaFlex™ has an exceptionally low carbon footprint when compared with that of steel; and

 

•

BasaFlex™ has a lower in-place cost: the physical nature of our products relative to steel result in a lower net cost to the contractor once installed, such as: BasaFlex™ is one-quarter of the weight of equivalent sized steel, meaning 4 times the quantity of material can be delivered by the same truck (or container); all Basanite products can be loaded/unloaded and moved around the jobsite by hand – no expensive handling equipment is needed; less concrete is required as BasaFlex™ does not require the extra concrete cover needed when using steel; and Basanite products are safer and easier to use. We believe all these factors materially reduce the net in-place cost of concrete reinforcement.

 

 

We believe that macroeconomic factors are pressuring the construction industry to consider the use of alternative reinforcement materials for the following reasons:

 

•

the increasing need for global infrastructure repair;

 

•

recent design trends towards increasing the lifespan of projects and materials;

 

•

the global interest in promoting the use of sustainable products; and

 

•

increasing consideration of both the long-term costs and environmental impacts of material selections.

 

We believe we are well positioned to benefit from this renewed focus, particularly in light of the interest of the U.S. government in funding infrastructure improvements and events such as the collapse of a residential building in Surfside, Florida.

 

Inflation & Interest Rate Sensitivity

 

In the past fiscal years, inflation has not had a significant impact on our business. However, during the second half of 2021, throughout 2022 and into 2023, the U.S. economy has entered into a period of increasing inflation. Should inflation persist or increase, interest rates rise and could have a significant effect on the economy in general and, thereby, could affect prices for raw materials we use, demand for our products, our ability to attract and retain skilled labor and our future operating results.

 

Supply Chain

 

In the past year, supply chain shortages or delays have had an immaterial impact on our operations. Our raw material suppliers have maintained a consistent flow of goods which we receive monthly. Domestic suppliers have increased their in-stock flows to maintain adequate levels with our manufacturing needs. However, we might experience supply chain challenges in the future, which could harm our business and our results of operations.

 

War in Ukraine

 

The recent war in Ukraine has led the world to issue sanctions on the government of Russia. This has shut down our ability to procure basalt fiber material from our secondary supplier, UWF/Kamenny Vek. However, our primary supplier, Mafic, is U.S. based, and has ample capacity to support our current and anticipated future needs with 100% domestic source of raw materials. We have also recently increased the levels of our safety stock of raw materials as an additional cushion. Nonetheless, we are currently qualifying alternate material from other suppliers to preserve our options in case of further disruptions.

 

Government Approvals and Specifying of our Products

 

We continue to pursue additional product and facility qualifications and approvals, and these qualifications and approvals are critical to the market acceptance of our products. BI is currently testing products at two independent laboratories and received ICC-ES certification, which was granted in the second quarter of 2023, and a Florida Department of Transportation (“FDOT”) production facility and product approval, which was also granted in the second quarter of 2023 (we are already selling to FDOT projects on an individual basis through exemptions or specs). The FDOT approval will allow us to bid on any project approved for BFRP. We anticipate that with these two approvals the prospects of new projects will increase.

 

 

Results of Operations

 

Revenue: We had revenue of $59,449 from sales of finished goods for the three months ended March 31, 2024, compared to $115,118 in the prior year. While the decrease in revenue in the year-over-year periods was relatively significant due to our manufacturing constraints and limited working capital.

 

Cost of goods sold: During the three months ended March 31, 2024, we had cost of sales of $4,258 compared to $19,751 in the prior year. We lost money on a gross margin basis due to normal inefficiencies in the start-up and ramping and scaling process, including limited initial sales volume, and further due to extremely narrow margins on the initial sales of our products as we began introducing them to the marketplace as well as limited manufacturing capabilities.

 

Operating Expenses

 

Sales, General, and Administrating Expenses: During the three months ended March 31, 2023, selling, general, and administrative were $129,071 compared to $429,714 in the prior year. The primary components of selling, general, and administrative expenses were as follows:

 

Payroll and related costs: During the three months ended March 31, 2024, payroll and related costs were $45,463 compared to $124,793 in the prior period. The decrease was due to the reduction of staff in 2023. The Company expects to return to a fully staffed operation by year end 2025.

 

Consulting fees: During the three months ended March 31, 2024, consulting fees were $0 compared to $49,615 in the prior period. The Company utilized financial consultants in the prior period in connection with its equity financing, management of the Company and fundraising.

 

Legal fees: During the three months ended March 31, 2023, legal fees were $36,235 compared to $6,155 in the prior period. Legal fees increased primarily due to ongoing matters in the current period.

 

Accounting and audit fees: During the three months ended March 31, 2024 accounting and audit fees were $30,000 compared to $22,155 in the prior period. Accounting and audit fees consisted of annual audit fees and the cost of outside consultants in the preparation of the Company’s financial statements.

 

Liquidity and Capital Resources

 

Since inception, we have incurred net operating losses and negative cash flow. As of March 31, 2024, we had an accumulated deficit of $56,525,090. We have incurred general and administrative expenses associated with our product development and compliance while concurrently setting up our manufacturing facility, beginning operations, and developing our business plan. We also continue to incur legal fees arising from ongoing activities due to fundraising. We expect operating losses to continue in the short term, and we require additional financing for expanding our manufacturing capability and generally scaling our business until we can generate sufficient revenues to achieve positive cash flow. These conditions raise substantial doubt about our ability to continue as a going concern.

 

We have historically satisfied our working capital requirements through the sale of restricted common stock and the issuance of warrants and promissory notes. We will continue our fundraising efforts until we have obtained positive cash flow to cover our expenses. No assurances can be given that we will be successful in raising capital at all or on terms acceptable to us, or at all, and no assurances can be given that even if we raise capital that we will be able to generate sufficient revenue to be cash flow positive.

 

Notwithstanding proceeds from the sale of our securities, a recent related party equipment lease transaction and warrant and option exercises in 2022 and 2023, current working capital is very limited and our projected sales revenue (together with our limited working capital) are presently insufficient to maintain our current operations. In order to grow our manufacturing and sales and marketing operations and reach the level of revenue sufficient to provide positive cash flow, we require significant funding of both our expansion plans (which includes the finalization of our current manufacturing expansion plans and potential investments in other manufacturing facilities, as well as increased headcount necessary to operate our manufacturing at planned capacity) as well as our significant operating deficit while we seeking to scale our manufacturing capability, secure orders from known potential customers and introduce our products to new customers. We will attempt to raise this capital through third party financing, including potential private or public offerings of our securities (including a potential underwritten offering and uplist to a national exchange) as well as bridge or other loan arrangements. However, there is a material risk that we will be unable to secure required capital (whether through an underwritten uplist financing or otherwise) at all or that the terms of such required financing may be available or acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results of operations may suffer, and our business may fail.

 

 

Cash Flows

 

Net cash provided by (used in) operating activities amounted to $1,148,247 and 1,859,981 for the three months ended March 31, 2024 and 2023, respectively. The decrease in net cash provided by (used in) operating activities was primarily a result of an decrease in operational activities.

 

During the three months ended March 31, 2023, we used $450,000 net cash for investing activities compared to $900,000 used in the same period in the prior fiscal year. The decrease is largely due to costs associated with the operational activities of day-to-day activities.

 

We do not believe that our cash on hand as of March 31, 2024, will be sufficient to fund our current working capital requirements to the point where we are generating positive cash flow. We have recently entered into several convertible promissory notes to help fund operations and will require additional working capital in the short term. We continue working towards securing more working capital with a preference towards debt which may be convertible to equity. However, there is no assurance that we will be successful in our efforts or, if we are, that the terms will be beneficial to our shareholders.

 

Critical Accounting Estimates

 

The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Please see note 2 to the condensed financial statements included in this report. 

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

ITEM 4.

CONTROLS AND PROCEDURES

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to be effective in providing reasonable assurance that information required to be disclosed in our reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management to allow timely decisions regarding required disclosure.

 

Our management, under the supervision and with the participation of our Acting Interim Chief Executive Officer and our Acting Interim Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Exchange Act) through March 31, 2024.

 

During our assessment of the effectiveness of internal control as of March 31, 2024, management identified material weaknesses related to (i) the U.S. GAAP expertise and experience of our internal accounting personnel and (ii) a lack of segregation of duties within accounting functions. As a result of these material weaknesses, our management concluded that our internal control  was not effective as of March 31, 2024.

 

We are committed to maintaining a strong internal control environment and implementing measures designed to help ensure that the material weaknesses described above are remediated as soon as possible. We believe we will have the opportunity to remediate these weaknesses when adequate funding is secured. We will consider the material weaknesses remediated after the applicable controls operate for a sufficient period of time, and management has concluded, through testing, that the controls are operating effectively.

 

Because of its inherent limitations, however, readers are cautioned that internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies and procedures may deteriorate.

 

Changes in Internal Control over Financial Reporting

 

No change in our system of internal control over financial reporting occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

PART II. – OTHER INFORMATION

 

ITEM 1.

LEGAL PROCEEDINGS

 

Legal Matters

 

From time to time, we may become involved in legal proceedings that, individually or in the aggregate, could have a material adverse effect on our business, financial condition, cash flows, or results of operations.

 

As of the date of this report, the Company has filed a lawsuit in the state of South Carolina against Upstate Custom Products, LLC. The lawsuit is based on the contract entered into by both parties in August 2021 in relation to the manufacturing of the protrusion machines exclusively manufactured by Upstate Custom Products. LLC. As of this filing the lawsuit and claim for relief is ongoing.

 

On or about October 2023, the Company was served notice of a pending matter of litigation with GS Capital Partners of New York regarding the liquidated damages fees from the 2021 PIPE investment. As of this filing the matter remains unresolved.

 

Due to our cash flow and liquidity challenges, we have received demand letters from several vendors to our company seeking payment of past due amounts to such vendors. As of the date of this report, such demands have not become formal litigations or other proceedings against our company, but they may become litigations against us in the future.

 

Except as set forth above, as of the date of this report, we are not aware of any proceedings pending against our company.

 

ITEM 1A.

RISK FACTORS

 

Not required for smaller reporting companies.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.

MINE SAFETY DISCLOSURE

 

Not applicable.

 

ITEM 5.

OTHER INFORMATION

 

Trading Plans

 

During the quarter ended March 31, 2024, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K).

 

ITEM 6.

EXHIBITS

 

Exhibit
No.		Exhibit Description
31.1		Certification of Chief Executive Officer pursuant to Rule 13A-14(a) or Rule 15d-14(a) of the Securities Exchange Act
31.2		Certification of Chief Financial Officer pursuant to Rule 13A-14(a) or Rule 15d-14(a) of the Securities Exchange Act
32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: May 24, 2024

	Basanite, Inc.
	By:	/s/ Jackie Placeres
		Jackie Placeres
		Acting Interim Chief Financial Officer

 

 

21

 

EXHIBIT 31.1

 

OFFICER’S CERTIFICATE
PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Ronald LoRicco, Sr., Acting Interim Chief Executive Officer, certify that:

  

1. I have reviewed this Form 10-Q for the quarter ended March 31, 2024, of Basanite, Inc.;

  

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15 (e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date:  May 24, 2024	By: /s/ Ronald LoRicco, Sr.
	Name: Ronald LoRicco, Sr.
	Title: Acting Interim Chief Executive Officer

 

 

 

EXHIBIT 31.2

 

OFFICER’S CERTIFICATE
PURSUANT TO RULE 13a-14(a)/15d-14(a)

 

I, Jackie Placeres, Acting Interim Chief Financial Officer, certify that:

  

1. I have reviewed this Form 10-Q for the quarter ended March 31, 2024, of Basanite, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15 (e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant issuer and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or cause such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:  May 24, 2024	By: /s/ Jackie Placeres
	Name: Jackie Placeres
	Title: Acting Interim Chief Financial Officer

 

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Basanite, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024 as filed with the United States Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

 

Date:  May 24, 2024	By: /s/ Ronald LoRicco, Sr.
	Name: Ronald LoRicco, Sr.
	Title: Acting Interim Chief Executive Officer (Principal Executive Officer)

 

 

A signed original of this written statement required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Basanite, Inc. and will be retained by Basanite, Inc. and furnished to the United States Securities and Exchange Commission or its staff upon request.

 

 

 

 

 

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Basanite, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the United States Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date:  May 24, 2024	By: /s/ Jackie Placeres
	Name:Jackie Placeres
	Title: Acting Interim Chief Financial Officer (Principal Accounting Officer)

 

A signed original of this written statement required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Basanite, Inc. and will be retained by Basanite, Inc. and furnished to the United States Securities and Exchange Commission or its staff upon request.

 

 

 

 

 

 

v3.24.1.1.u2

Cover - shares	3 Months Ended
	Mar. 31, 2024	May 17, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	000-53574
Entity Registrant Name	Basanite, Inc.
Entity Central Index Key	0001448705
Entity Tax Identification Number	20-4959207
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2660 NW 15th Court
Entity Address, Address Line Two	Unit 108
Entity Address, City or Town	Pompano Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33069
City Area Code	954
Local Phone Number	532-4653
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		260,156,796

v3.24.1.1.u2

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Dec. 31, 2023
CURRENT ASSETS
Cash	$ 3,791	$ 55,248
Accounts receivable, net	36,391	40,222
TOTAL CURRENT ASSETS	40,182	95,470
Lease right-of-use asset, operating	32,759	56,915
Fixed assets, net	370,309	402,271
TOTAL NON–CURRENT ASSETS	403,068	459,186
TOTAL ASSETS	443,250	554,656
CURRENT LIABILITIES
Accounts payable	1,789,184	1,762,390
Accrued expenses	1,288,459	1,207,545
Due to shareholders	475,000	475,000
Notes payable	270,000	270,000
Notes payable - related party	1,828,000	1,750,000
Notes payable - convertible - related party, net	2,144,357	2,144,357
Lease liability - current portion	32,759	56,915
TOTAL CURRENT LIABILITIES	7,827,759	7,666,207
TOTAL LIABILITIES	7,827,759	7,666,207
STOCKHOLDERS’ (DEFICIT) EQUITY
Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding
Common stock, $0.001 par value, 1,000,000,000 shares authorized, 260,156,796 and 259,156,796 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	260,157	259,157
Additional paid-in capital	48,905,681	48,891,681
Accumulated deficit	(56,550,347)	(56,262,389)
TOTAL STOCKHOLDERS’ (DEFICIT) EQUITY	(7,384,509)	(7,111,551)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 443,250	$ 554,656

v3.24.1.1.u2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	260,156,796	259,156,796
Common stock, shares outstanding	260,156,796	259,156,796

v3.24.1.1.u2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Products sales	$ 59,449	$ 115,118
Total cost of goods sold	4,259	19,751
Gross (loss) profit	55,191	95,367
OPERATING EXPENSES
Sales, general, and administrative	154,329	434,784
Total operating expenses	154,329	434,784
NET LOSS FROM OPERATIONS	(99,139)	(339,417)
OTHER INCOME (EXPENSE)
Interest expense	(188,819)	(129,037)
Total other income (expense)	(188,819)	(129,037)
NET LOSS	$ (287,958)	$ (468,454)
Net loss per share –
Basic	$ (0.00)	$ (0.00)
Diluted	$ (0.00)	$ (0.00)
Weighted average number of shares outstanding –
Basic	259,690,129	253,217,402
Diluted	259,690,129	253,217,402

v3.24.1.1.u2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2022	$ 0	$ 253,218	$ 47,433,354	$ (52,642,392)	$ (6,406,438)
Beginning balance, shares at Dec. 31, 2022	0	253,217,402
Stock based compensation			64,266
Net loss				(468,454)	(2,299,422)
Ending balance, value at Mar. 31, 2023	$ 0	$ 253,218	47,497,620	(54,561,464)	(6,810,626)
Ending balance, shares at Mar. 31, 2023	0	253,217,402
Beginning balance, value at Dec. 31, 2023	$ 0	$ 259,157	48,891,681	(56,262,389)	(7,111,551)
Beginning balance, shares at Dec. 31, 2023	0	259,156,796
Stock based compensation		$ 1,000	14,000		15,000
Stock-based compensation, shares		1,000,000
Net loss				(287,958)	(287,958)
Ending balance, value at Mar. 31, 2024	$ 0	$ 260,157	$ 48,905,681	$ (56,550,347)	$ (7,384,509)
Ending balance, shares at Mar. 31, 2024	0	260,156,796

v3.24.1.1.u2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (287,958)	$ (468,454)
Adjustments to reconcile net loss to net cash used in operating activities:
Lease right-of-use asset amortization	24,156	25,981
Depreciation	31,962	32,064
Stock-based compensation	15,000	64,226
Changes in operating assets and liabilities:
Prepaid expenses	0	26,336
Accounts receivable	3,831	(242)
Accounts payable and accrued expenses	107,708	258,009
Subscription liability	0	0
Lease liability	(24,156)	(22,812)
Net cash used in operating activities	(129,457)	(84,852)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities	0	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock, net	0	0
Proceeds from exercise of stock options	0	0
Proceeds from notes payable and notes payable related party	78,000	90,000
Repayments of notes payable and notes payable related party	0	(4,785)
Net cash provided by financing activities	78,000	85,215
NET INCREASE IN CASH	(51,457)	363
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	55,248	30,340
CASH AND CASH EQUIVALENTS AT END OF PERIOD	3,791	30,703
Supplemental cash flow information:
Cash paid for interest	0	0
Cash paid for taxes	$ 0	$ 0

v3.24.1.1.u2

Pay vs Performance Disclosure - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss) Attributable to Parent	$ (287,958)	$ (468,454)

v3.24.1.1.u2

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

v3.24.1.1.u2

ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN	NOTE 1 – ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN   (A) Description of Business   Basanite, Inc., a Nevada corporation (the “Company”, “Basanite”, “we”, “us”, “our” or similar terminology), through our wholly owned subsidiary, Basanite Industries, LLC, a Delaware limited liability company (“BI”), manufactures a range of “green” (environmentally friendly), sustainable, non-corrosive, lightweight, composite products used in concrete reinforcement by the construction industry. Our core product is BasaFlex™, a basalt fiber reinforced polymer reinforcing bar (“rebar”) which we believe is a stronger, lighter, sustainable, non-conductive and corrosion-proof alternative to traditional steel.   Our two other main product lines are BasaMix™, which are fine denier basalt fibers available in various sizes, and BasaMesh™, a line of Basalt Geogrid Mesh Rolls, intended to replace welded wire mesh (made of steel) and other fiber reinforced polymer (“FRB”) grids and mesh.   BasaMix™ is designed to help absorb the stresses associated with early-aged plastic shrinkage and settlement cracking in concrete, as well as providing an increased toughness for enhanced reinforcement in Slab-on-Grade ("SOG”) and precast elements. BasaMix™ also serves in a “system approach” for optimum performance of a concrete element when used in conjunction with our BasaFlex™ rebar.   BasaMesh™ is designed for secondary and temperature shrinkage reinforcement. BasaMesh™ can also work in conjunction with the BasaFlex™ rebar or BasaMix™ for a total reinforcement program.   Each of our products is specifically designed to extend the lifecycle of concrete products by eliminating “concrete spalling.” Spalling results from the steel reinforcing materials embedded within the concrete member rusting (contrary to popular belief, concrete is porous and water can permeate into concrete). Rusting leads to the steel expanding and eventually causing the surrounding concrete to delaminate, crack, or even break off, resulting in potential structural failure. We believe that each Basanite product addresses this important need along with other key requirements in today’s construction market.   (B) Liquidity and Management Plans   Since inception, the Company has incurred net operating losses and used cash in operations. As of March 31, 2024, and December 31, 2023, respectively, the Company reported:   • an accumulated deficit of $56.6 million and $56.3 million;   • a working capital deficiency of $7.8 million and $7.6 million; and   • cash used in operations of $129.4 thousand   Losses have principally occurred as a result of the substantial resources required for product research and development and for marketing of the Company’s products; including the general and administrative expenses associated with the organization.   While we have generated relatively little revenue to date, revenue from sales of product began to increase in the quarter ended March 31, 2021, and we continue to receive inquiries and solicit orders from a range of customers for our products, indicating what we believe is a significant level of market interest for BasaFlex™. While the Company expects to expand its manufacturing capacity during 2025, based on our current limited manufacturing capacity there is no guarantee that orders will actually be received or that orders, if received, can be properly fulfilled.   We have historically satisfied our working capital requirements through the sale of restricted common stock of the Company, $0.001 par value per share (the “Common Stock”), and the issuance of warrants to purchase Common Stock and promissory notes. Until we are able to internally generate meaningful revenue and positive cash flow, we will attempt to fund working capital requirements through third party financing, including through potential private or public offerings of our securities as well as bridge or other loan arrangements. However, a number of factors continue to hinder the Company’s ability to attract new capital investment. We cannot provide any assurances that the required capital will be obtained at all, or that the terms of such required capital may be acceptable to us. If we are unable to obtain adequate financing, we may reduce our operating activities to reduce our cash use until sufficient funding is secured. If we are unable to secure funding when needed, our results of operations may suffer, and our business may fail.   These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties.

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES   (A) Use of Estimates in Financial Statements   The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is typically estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying Common Stock, the expected term of the option, the expected volatility of the price of our Common Stock, risk-free interest rates and the expected dividend yield of our Common Stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.   The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the three months ended March 31, 2024 and 2023, respectively:   Schedule of fair value assumptions of warrants and options issued                 Three months     Three months       ended     ended       March 31,     March 31,       2023     2022   Expected price volatility     —         176.23 % Risk-free interest rate     —         5.63   Expected life in years     —         5   Dividend yield     —         —       (B) Principles of Consolidation   The condensed consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC. All intercompany balances have been eliminated in consolidation. The Company’s operations are conducted primarily through Basanite Industries, LLC. Basalt America, LLC is currently inactive.   (C) Cash   The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company “("FDIC") up to $250,000. The Company’s credit risk in the event of failure of these financial institutions is represented by the difference between the FDIC limit and the total amounts on deposit. Management monitors the financial institutions credit worthiness in conjunction with balances on deposit to minimize risk. The Company from time to time may have amounts on deposit in excess of the insured limits.   (D) Inventories   The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at lower of cost or net realizable value. Cost is determined on the first-in, first-out basis. Raw materials inventory consists of basalt fiber and other necessary elements to produce the basalt rebar. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value. The Company had no inventory as of March 31, 2024 and December 31, 2023.   (E) Fixed assets   Fixed assets consist of the following:   Schedule of fixed assets                     March 31,     December 31,       2024     2023       (Unaudited)         Computer equipment   $ 224,473     $ 224,473   Machinery     728,245       728,245   Construction in process     —         —           931,438       931,438   Accumulated depreciation     (561,129 )     (529,168 )     $ 370,309     $ 402,270     Depreciation expense for the three months ended March 31, 2024 was $31,962 compared to $32,064 for the three months ended March 31, 2023.   (F) Deposits and other current assets   The Company’s deposits and other current assets consist of the deposits made on equipment, security deposits, utility deposits and other receivables. The deposits are reclassified as part of the fixed asset cost when received and placed into service.   (G) Loss Per Share   The basic loss per share is calculated by dividing the Company's net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company's net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.   The following are potentially dilutive shares not included in the loss per share computation:   Schedule of dilutive shares not included in the loss per share computation                     March 31,     December 31,       2024     2023       (Unaudited)         Options     1,277,778       1,477,778   Warrants     129,699,090       125,295,757   Convertible securities     8,016,068       8,016,068   Total     138,992,936       134,789,603     (H) Stock-Based Compensation   The Company recognizes compensation costs to employees under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant. The Company recognized $0 in stock-based compensation during the three months ended March 31, 2024.   (I) Revenue Recognition   We recognize revenue when control of the promised goods or services is transferred to the Company’s customers in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. The timing of revenue recognition largely is dependent on shipping terms. Revenue is recorded at the time of shipment for terms designated free on board (“FOB”) shipping point. For sales transactions designated FOB destination, revenue is recorded when the product is delivered to the customer’s delivery site.   All revenues recognized are net of trade allowances, cash discounts, and sales returns. Trade allowances are based on the estimated obligations. Adjustments to earnings resulting from revisions to estimates on discounts and returns have been immaterial for each of the reported periods. Shipping and handling amounts billed to a customer as part of a sales transaction are included in revenues, and the related costs are included in cost of goods sold. Shipping and handling is treated as a fulfillment activity, rather than a promised service, and therefore is not considered a separate performance obligation. During the three months ended March 31, 2023 and 2022, the Company incurred shipping and handling costs in the amount of $6,340 and $8,355, respectively.

v3.24.1.1.u2

OPERATING LEASE	3 Months Ended
	Mar. 31, 2024
Operating Lease
OPERATING LEASE	NOTE 3 – OPERATING LEASE   On January 18, 2019, the Company entered into an agreement to lease approximately 25,470 square feet of office and manufacturing space in Pompano Beach, Florida through March 2024. On March 25, 2019, the Company entered into an amendment to the agreement to increase the square footage of leased premises to 36,900 square feet, increasing the Company’s base rent obligation to be approximately $33,825 per month for one year and nine months, and increasing annually at a rate of three percent for the remainder of the lease term.   On December 31, 2022 the Company vacated the lease, as of this filing the Company has not entered into a new commercial lease for a manufacturing facility. The Company is actively engaged in a nation-wide search to secure a manufacturing facility.   For the three months ended March 31, 2024 and 2023, the Company expensed $0, respectively for rent.

v3.24.1.1.u2

NOTES PAYABLE	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
NOTES PAYABLE	NOTE 4 – NOTES PAYABLE   Notes payable totaled $270,000 and $299,458 for March 31, 2024, and December 31, 2023, respectively.   On April 2, 2021, the Company issued a promissory note with an investor in exchange for $200,000 bearing an interest rate of 18% per annum and payable on October 2, 2022. The Company also issued a warrant to purchase 2,000,000 shares of Common Stock at an exercise price of $0.20 per share expiring in 5 years. The note was not paid by its due date. As of the date of this filing, the noteholder has not issued a formal demand for payment and the Company is in negotiations with the noteholder to remedy the past-due status.   On April 9, 2021, the Company issued a promissory note with an investor in exchange for $50,000 bearing an interest rate of 18% per annum and payable on October 9, 2022. The Company also issued a warrant to purchase 500,000 shares of Common Stock at an exercise price of $0.20 per share expiring in 5 years. The note was not paid by its due date. As of the date of this filing, the noteholder has not issued a formal demand for payment and the Company is in negotiations with the noteholder to remedy the past-due status.   On April 16, 2021, the Company issued a promissory note with an investor in exchange for $25,000 bearing an interest rate of 18% per annum and payable on October 16, 2022. The Company also issued a warrant to purchase 250,000 shares of Common Stock at an exercise price of $0.25 per share expiring in 5 years. The note was not paid by its due date. As of the date of this filing, the noteholder has not issued a formal demand for payment and the Company is in negotiations with the noteholder to remedy the past-due status.   During the three months ended March 31, 2024, the Company made principal payments in the amount of $0 on notes payable.   Interest expense for the Company’s notes payable for the three months ended March 31, 2024 was $17,034 compared to $17,051 for the three months ended March 31, 2023.   Accrued interest for the Company’s notes payable on March 31, 2024 and December 31, 2023 was $176,664 and $159,630, respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

v3.24.1.1.u2

NOTES PAYABLE – RELATED PARTY	3 Months Ended
	Mar. 31, 2024
Notes Payable Related Party
NOTES PAYABLE – RELATED PARTY	NOTE 5 – NOTES PAYABLE – RELATED PARTY   Notes payable - related party totaled $1,828,000 March 31, 2024 and $1,750,000 December 31, 2023, respectively.   On January 16, 2020, the Company entered into a demand note agreement with our Board Chairman, Michael V. Barbera, in the amount of $50,000. The note has a term of 6 months bearing an interest rate of 10% per annum. On April 13, 2020, an addendum was executed changing the terms of the note to a convertible note payable bearing an interest rate of 12% per annum. Per the addendum, the principal and accrued interest is convertible at the option of the holder after June 5, 2020 at a 20% discount of that days’ closing price. See Note 6 for information regarding this convertible note payable – related party.   On April 2, 2021, the Company issued a promissory note with Paul Sallarulo, a member of our Board of Directors, in exchange for $150,000 bearing an interest rate of 18% per annum and payable on October 2, 2022. The company also issued 1,500,000 common stock warrants at an exercise price of $0.20 per share expiring in 5 years. The note was not paid by its due date. On April 2, 2022, the due date of this note was extended to April 1, 2024. As of the date of this report, the note has not been called.   On April 2, 2021, the Company issued a promissory note with Michael V. Barbera, our Chairman of the Board, in exchange for $150,000 bearing an interest rate of 18% per annum and payable on October 2, 2022. The company also issued 1,500,000 common stock warrants at an exercise price of $0.20 per share expiring in 5 years. The note was not paid by its due date. On April 2, 2022, the due date of this note was extended to April 1, 2024. As of the date of this report, the note has not been called.   On August 31, 2022 the Company issued a promissory note to a board member in exchange for $37,000 bearing an interest rate of 10% per annum and payable on August 31, 2024.   On August 22, 2022 the Company issued a promissory note to a board member in exchange for $20,000 bearing an interest rate of 10% per annum and payable on August 22, 2024.   On August 22, 2022 the Company issued a promissory note to a board member in exchange for $5,000 bearing an interest rate of 10% per annum and payable on August 22, 2024.   On August 29, 2022 the Company issued a promissory note to a board member in exchange for $25,000 bearing an interest rate of 10% per annum and payable on August 29, 2024.   On August 29, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on August 29, 2024.   On August 31, 2022 the Company issued a promissory note to a board member in exchange for $13,000 bearing an interest rate of 10% per annum and payable on August 31, 2024.   On September 9, 2022 the Company issued a promissory note to a board member in exchange for $60,000 bearing an interest rate of 10% per annum and payable on August 16, 2024.   On September 9, 2022 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 10% per annum and payable on September 9, 2024.   On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $10,000 bearing an interest rate of 10% per annum and payable on September 9, 2024.   On September 9, 2022 the Company issued a promissory note to a strategic partner in exchange for $15,000 bearing an interest rate of 10% per annum and payable on September 9, 2024.   On September 9, 2022 the Company issued a promissory note to an investor and advisor to the board, in exchange for $15,000 bearing an interest rate of 10% per annum and payable on September 9, 2024.   On September 22, 2022 the Company issued a promissory note to a board member in exchange for $42,500 bearing an interest rate of 18% per annum and payable on September 22, 2024.   On February 14, 2023 the Company issued a promissory note to a board member in exchange for $10,000 bearing an interest rate of 20% per annum and payable on February 13, 2024.   On February 24, 2023 the Company issued a promissory note to a board member in exchange for $50,000 bearing an interest rate of 20% per annum and payable on February 23, 2024.   On March 3, 2023 the Company issued a promissory note to a board member in exchange for $15,000 bearing an interest rate of 20% per annum and payable on March 2, 2024.   On March 24, 2023 the Company issued a promissory note to a board member in exchange for $15,000 bearing an interest rate of 20% per annum and payable on March 23, 2024.   On April 12, 2023 the Company issued a promissory note to a board member in exchange for $150,000 bearing an interest rate of 20% per annum and payable on April 11, 2024.   On April 28, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable on April 27, 2024.   On May 12, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable on May 11, 2024.   On June 5, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable on June 4, 2024.   On July 25, 2023 the Company issued a promissory note to a board member in exchange for $200,000 bearing an interest rate of 20% per annum and payable on July 24, 2024.   On September 11, 2023 the Company issued a promissory note to a board member in exchange for $150,000 bearing an interest rate of 20% per annum and payable on September 10, 2024.   On September 11, 2023 the Company issued a promissory note to an advisor to the board in exchange for $50,000 bearing an interest rate of 20% per annum and payable on September 10, 2024.   On November 2, 2023 the Company issued a promissory note to a board member in exchange for $100,000 bearing an interest rate of 20% per annum and payable on November 1, 2024.   On December 12, 2023 the Company issued a promissory note to a board member in exchange for $75,000 bearing an interest rate of 20% per annum and payable on December 11, 2024.   On January 9, 2024 the Company issued a promissory note to a board member in exchange for $23,000 bearing an interest rate of 20% per annum and payable on January 8, 2025.   On March 6, 2024 the Company issued a promissory note to a board member in exchange for $40,000 bearing an interest rate of 20% per annum and payable on March 5, 2025.   On March 21, 2024 the Company issued a promissory note to a board member in exchange for $15,000 bearing an interest rate of 20% per annum and payable on March 20, 2025.   Interest expense for the Company’s notes payable – related party for the three months ended March 31, 2024 and 2023 was $25,750 and $23,599, respectively.   Accrued interest for the Company’s notes payable - related party on March 31, 2023, and December 31, 2023, was $1,213,507 and $996,963, respectively, and is included in accrued expenses on the accompanying condensed consolidated balance sheets.

v3.24.1.1.u2

NOTES PAYABLE – CONVERTIBLE – RELATED PARTY	3 Months Ended
	Mar. 31, 2024
Notes Payable Convertible Related Party
NOTES PAYABLE – CONVERTIBLE – RELATED PARTY	NOTE 6 – NOTES PAYABLE – CONVERTIBLE – RELATED PARTY   Convertible Notes payable – related party totaled $2,144,357 on March 31, 2024, and December 31, 2023.   On August 3, 2020, the Company issued a secured convertible promissory note to certain investors in exchange for $ 1,000,000 in the aggregate bearing an interest rate of 20% per annum and payable in 6 months. The holder may convert the unpaid principal balance of the note into shares of restricted Common Stock at the conversion price equal to $0.275 per share, which conversion price was set with the consummation of the Company’s private placement of Units which closed on August 17, 2021. This note contains a negative covenant that requires the Company to obtain consent prior to incurring any additional equity or debt investments and is secured by all of the assets of the Company. The Richard A. LoRicco Sr. and Lucille M. LoRicco Irrevocable Insurance Trust DTD 4/28/95, Louis Demaio as Trustee (the “Trust”) is the holder of $ 750,000 of the principal amount of this note. The Trust was created by Richard A. LoRicco Sr. and Lucille M. LoRicco, who were the parents of Ronald J. LoRicco Sr., one of the members of the Company’s Board of Directors and is maintained by an independent trustee. Ronald J. LoRicco Sr. does not have voting or investment control of or power over the Trust but is an anticipated, partial beneficiary of the Trust.   On February 12, 2021, the Company exchanged the original debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $1,610,005 bearing an interest rate of 20% per annum and fully payable in 3 months. This was accounted for as a debt extinguishment and the new promissory note was recorded at fair value in accordance with ASC 470 “Debt”. The original principal of $1,000,000 and accrued interest of $110,005 calculated as of the date of amendment and restatement along with an additional advance of $500,000 determined the principal amount of the new note. In consideration of the additional advance and the extension of the maturity date of the original note, the Company issued to the noteholders 5-year warrants to purchase an aggregate of 15,000,000 shares of Common Stock with an exercise price of $0.20 per share. The issuance of the warrants for the extension generated a loss on extinguishment of $3,686,123 for the fair value of the warrants issued.   On May 12, 2021, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $1,689,746 bearing an interest rate of 20% per annum and fully payable February 12, 2022. The original principal of $1,610,005 and accrued interest of $79,742 calculated as of the date of amendment and restatement determined the principal amount of the new note. In consideration of the additional advance and the extension of the maturity date of the original note, the Company issued to the noteholders 5-year warrants to purchase an aggregate of 7,500,000 shares of common stock with an exercise price of $0.35 per share. The issuance of the warrants for the extension generated a loss on extinguishment of $1,874,705 for the fair value of the warrants issued. The note was not paid by its due date of February 12, 2022. As of the date of this filing, the noteholder has not issued a formal demand for payment and the Company is in negotiations with the noteholder to remedy the past-due status.   On September 15, 2022, the Company extended the debt for a newly issued amended and restated secured convertible promissory note with a new principal balance of $2,027,695 bearing an interest rate of 20% per annum and fully payable February 12, 2023. The amended principal of $1,689,746 and accrued interest of $454,612 calculated as of the date of amendment and restatement determined the principal amount of the new note. No additional consideration was provided.   Interest expense for the Company’s convertible notes payable – related parties for the three months ended March 31, 2024, was $107,218 and for the three months ended March 31, 2023, respectively.   Accrued interest for the Company’s convertible notes payable – related parties on March 31, 2024 and December 31, 2023, was $665,430 and $558,212, respectively, and is included in accrued expenses on the condensed consolidated balance sheets.

v3.24.1.1.u2

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 7 – COMMITMENTS AND CONTINGENCIES   The Company is the obligor under certain promissory notes that are currently past due (although formal events of default have not been declared).   See notes 4 and 5.   The Company is presently in default of its obligations under the terms of the Company’s private placement which closed in August 2021 to file a registration statement for an underwritten public offering and concurrently listing on a national stock exchange. As a result, the Company is required to pay liquidated damages in the amount of $53,345 per month starting in March 2022, and the maximum amount of such liquidated damages could be approximately $480,000 if such filing is not made.   On August 17, 2021, the Company conducted the closing of a private placement offering to accredited investors of the Company’s units at a price of $0.275 per unit, with each unit consisting of: (i) one share of the Company’s common stock, (ii) a five-year, immediately exercisable warrant (“Warrant A”) to purchase one share of common stock at an exercise price of $0.33 per share and (iii) an additional five-year, immediately exercisable warrant to purchase one share of common stock at an exercise price of $0.33 per share (“Warrant B”). The Warrant A and Warrant B are identical, except that the Warrant B has a call feature in favor of the Company, as defined in the offering agreements. In connection with the closing, the Company entered into definitive securities purchase agreements with 19 accredited investors and issued an aggregate of 19,398,144 shares of common stock, Warrant A to purchase up to an aggregate of 19,398,144 shares of common stock, and Warrant B to purchase up to an aggregate of 19,398,144 shares of Common Stock (for an aggregate of 38,796,288 Warrant Shares), for aggregate gross proceeds to the Company of approximately $5,334,490. Costs of the offering in the amount of $611,603 were charge to additional paid in capital. As of December 31, 2022 the Company also accrued the amount of $386,759 as liquidated damages due to the investors in the Company’s August 2021 private placement, such liquidated damages being related to the Company’s failure to timely file a registration statement on Form S-1 for an underwritten public offering and concurrent listing of the Common Stock on a national exchange.

v3.24.1.1.u2

STOCKHOLDERS’ DEFICIT	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 8 – STOCKHOLDERS’ DEFICIT   During the three months ended March 31, 2024, the Company issued 1,000,000 shares of common stock to our former CEO. The shares were valued at the closing stock price on the date of grant for a total value of $15,000 recorded in stock-based compensation.

v3.24.1.1.u2

OPTIONS AND WARRANTS	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
OPTIONS AND WARRANTS	NOTE 9 – OPTIONS AND WARRANTS   Stock Options:   The following table provides the activity in options for the respective periods:   Schedule of option activity                             Total Options     Weighted Average     Aggregate Intrinsic       Outstanding     Exercise Price     Value                       Balance at January 1, 2023     1,477,778       0.27     $ —     Issued     —         0.27       —     Cancelled / Expired     —         0.27       —                               Balance at December 31, 2023     1,477,778     $ 0.27     $ —     Exercised     —         0.27       —     Cancelled / Expired     (2,000,000 )     0.27       —     Balance at March 31, 2024     1,277,778     $ 0.27     $ —       Options exercisable and outstanding at March 31, 2023 are as follows: Schedule of options exercisable and outstanding                   Range of Exercise Prices   Number Outstanding   Weighted Average Remaining Contractual Life (Years)   Weighted Average Exercise Price   Aggregate Intrinsic Value                       $0.01 - $0.50   1,277,778   2.14   $0.27   —     See note 8.   Stock Warrants:   The following table provides the activity in warrants for the respective periods:   Schedule of warrants activity                             Total     Weighted Average     Aggregate Intrinsic       Warrants     Exercise Price     Value                       Balance at January 1, 2023     139,555,757     $ 0.29     $ 150,667   Granted     2,000,000       0.29       —     Exercised     —         0.29       —     Cancelled     (16,260,000 )                                           Balance at December 31, 2023     125,295,757     $ 0.29     $ 135,272   Granted     4,403,333       0.29       —     Balance at March 31, 2024     129,699,090     $ 0.29     $ —       Warrants exercisable and outstanding at March 31, 2023 are as follows: Schedule of warrants exercisable and outstanding                   Range of Exercise Prices   Number Outstanding   Weighted Average Remaining Contractual Life (Years)   Weighted Average Exercise Price   Aggregate Intrinsic Value                       $0.01 - $0.50   129,699,090   2.07   $0.29   $—   $0.51 - $1.00   —   0.85   $0.60   —       129,699,090           $150,667

v3.24.1.1.u2

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS   None.

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Use of Estimates in Financial Statements	(A) Use of Estimates in Financial Statements   The presentation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   Stock-based compensation and stock awards related to convertible debt instruments are recognized based on the fair value of the awards granted. The fair value of each award or conversion feature is typically estimated on the grant date using the Black-Scholes pricing model. The Black-Scholes pricing model requires the input of highly subjective assumptions, including the fair value of the underlying Common Stock, the expected term of the option, the expected volatility of the price of our Common Stock, risk-free interest rates and the expected dividend yield of our Common Stock. The assumptions used to determine the fair value of the stock awards represent management’s best estimates. These estimates involve inherent uncertainties and the application of management’s judgment.   The Company used the Black Scholes valuation model to determine the fair value of the warrants and options issued, using the following key assumptions for the three months ended March 31, 2024 and 2023, respectively:   Schedule of fair value assumptions of warrants and options issued                 Three months     Three months       ended     ended       March 31,     March 31,       2023     2022   Expected price volatility     —         176.23 % Risk-free interest rate     —         5.63   Expected life in years     —         5   Dividend yield     —         —
Principles of Consolidation	(B) Principles of Consolidation   The condensed consolidated financial statements include the accounts of Basanite, Inc. and its wholly owned subsidiaries, Basanite Industries, LLC and Basalt America, LLC. All intercompany balances have been eliminated in consolidation. The Company’s operations are conducted primarily through Basanite Industries, LLC. Basalt America, LLC is currently inactive.
Cash	(C) Cash   The Company considers all highly liquid temporary cash instruments with an original maturity of three months or less to be cash equivalents. The Company places its cash, cash equivalents and restricted cash on deposit with financial institutions in the United States, which are insured by the Federal Deposit Insurance Company “("FDIC") up to $250,000. The Company’s credit risk in the event of failure of these financial institutions is represented by the difference between the FDIC limit and the total amounts on deposit. Management monitors the financial institutions credit worthiness in conjunction with balances on deposit to minimize risk. The Company from time to time may have amounts on deposit in excess of the insured limits.
Inventories	(D) Inventories   The Company’s inventories consist of raw materials, work in process and finished goods, both purchased and manufactured. Inventories are stated at lower of cost or net realizable value. Cost is determined on the first-in, first-out basis. Raw materials inventory consists of basalt fiber and other necessary elements to produce the basalt rebar. On a quarterly basis, the Company analyzes its inventory levels and records allowances for inventory that has become obsolete and inventory that has a cost basis in excess of the expected net realizable value. The Company had no inventory as of March 31, 2024 and December 31, 2023.
Fixed assets	(E) Fixed assets   Fixed assets consist of the following:   Schedule of fixed assets                     March 31,     December 31,       2024     2023       (Unaudited)         Computer equipment   $ 224,473     $ 224,473   Machinery     728,245       728,245   Construction in process     —         —           931,438       931,438   Accumulated depreciation     (561,129 )     (529,168 )     $ 370,309     $ 402,270     Depreciation expense for the three months ended March 31, 2024 was $31,962 compared to $32,064 for the three months ended March 31, 2023.
Deposits and other current assets	(F) Deposits and other current assets   The Company’s deposits and other current assets consist of the deposits made on equipment, security deposits, utility deposits and other receivables. The deposits are reclassified as part of the fixed asset cost when received and placed into service.
Loss Per Share	(G) Loss Per Share   The basic loss per share is calculated by dividing the Company's net loss available to common shareholders by the weighted average number of common shares during the period. The diluted loss per share is calculated by dividing the Company's net loss by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity.   The following are potentially dilutive shares not included in the loss per share computation:   Schedule of dilutive shares not included in the loss per share computation                     March 31,     December 31,       2024     2023       (Unaudited)         Options     1,277,778       1,477,778   Warrants     129,699,090       125,295,757   Convertible securities     8,016,068       8,016,068   Total     138,992,936       134,789,603
Stock-Based Compensation	(H) Stock-Based Compensation   The Company recognizes compensation costs to employees under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718, Compensation – Stock Compensation. Under FASB ASC Topic 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the grant. The Company recognized $0 in stock-based compensation during the three months ended March 31, 2024.
Revenue Recognition	(I) Revenue Recognition   We recognize revenue when control of the promised goods or services is transferred to the Company’s customers in an amount that reflects the consideration we expected to be entitled to in exchange for those goods or services. The timing of revenue recognition largely is dependent on shipping terms. Revenue is recorded at the time of shipment for terms designated free on board (“FOB”) shipping point. For sales transactions designated FOB destination, revenue is recorded when the product is delivered to the customer’s delivery site.   All revenues recognized are net of trade allowances, cash discounts, and sales returns. Trade allowances are based on the estimated obligations. Adjustments to earnings resulting from revisions to estimates on discounts and returns have been immaterial for each of the reported periods. Shipping and handling amounts billed to a customer as part of a sales transaction are included in revenues, and the related costs are included in cost of goods sold. Shipping and handling is treated as a fulfillment activity, rather than a promised service, and therefore is not considered a separate performance obligation. During the three months ended March 31, 2023 and 2022, the Company incurred shipping and handling costs in the amount of $6,340 and $8,355, respectively.

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Schedule of fair value assumptions of warrants and options issued	Schedule of fair value assumptions of warrants and options issued                 Three months     Three months       ended     ended       March 31,     March 31,       2023     2022   Expected price volatility     —         176.23 % Risk-free interest rate     —         5.63   Expected life in years     —         5   Dividend yield     —         —
Schedule of fixed assets	Schedule of fixed assets                     March 31,     December 31,       2024     2023       (Unaudited)         Computer equipment   $ 224,473     $ 224,473   Machinery     728,245       728,245   Construction in process     —         —           931,438       931,438   Accumulated depreciation     (561,129 )     (529,168 )     $ 370,309     $ 402,270
Schedule of dilutive shares not included in the loss per share computation	Schedule of dilutive shares not included in the loss per share computation                     March 31,     December 31,       2024     2023       (Unaudited)         Options     1,277,778       1,477,778   Warrants     129,699,090       125,295,757   Convertible securities     8,016,068       8,016,068   Total     138,992,936       134,789,603

v3.24.1.1.u2

OPTIONS AND WARRANTS (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of option activity	Schedule of option activity                             Total Options     Weighted Average     Aggregate Intrinsic       Outstanding     Exercise Price     Value                       Balance at January 1, 2023     1,477,778       0.27     $ —     Issued     —         0.27       —     Cancelled / Expired     —         0.27       —                               Balance at December 31, 2023     1,477,778     $ 0.27     $ —     Exercised     —         0.27       —     Cancelled / Expired     (2,000,000 )     0.27       —     Balance at March 31, 2024     1,277,778     $ 0.27     $ —
Schedule of options exercisable and outstanding	Schedule of options exercisable and outstanding                   Range of Exercise Prices   Number Outstanding   Weighted Average Remaining Contractual Life (Years)   Weighted Average Exercise Price   Aggregate Intrinsic Value                       $0.01 - $0.50   1,277,778   2.14   $0.27   —
Schedule of warrants activity	Schedule of warrants activity                             Total     Weighted Average     Aggregate Intrinsic       Warrants     Exercise Price     Value                       Balance at January 1, 2023     139,555,757     $ 0.29     $ 150,667   Granted     2,000,000       0.29       —     Exercised     —         0.29       —     Cancelled     (16,260,000 )                                           Balance at December 31, 2023     125,295,757     $ 0.29     $ 135,272   Granted     4,403,333       0.29       —     Balance at March 31, 2024     129,699,090     $ 0.29     $ —
Schedule of warrants exercisable and outstanding	Schedule of warrants exercisable and outstanding                   Range of Exercise Prices   Number Outstanding   Weighted Average Remaining Contractual Life (Years)   Weighted Average Exercise Price   Aggregate Intrinsic Value                       $0.01 - $0.50   129,699,090   2.07   $0.29   $—   $0.51 - $1.00   —   0.85   $0.60   —       129,699,090           $150,667

v3.24.1.1.u2

ORGANIZATION, NATURE OF BUSINESS AND GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 56,600,000	$ 56,300,000
Working capital deficiency	7,800,000	7,600,000
Cash used in operations	$ 129,400	$ 129,400

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Fair Value of Warrants and Options) (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounting Policies [Abstract]
Expected price volatility	0.00%	176.23%
Risk-free interest rate	0.00%	5.63%
Expected life in years		5 years
Dividend yield	$ 0	$ 0

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Fixed assets) (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 931,438	$ 931,438
Accumulated depreciation	(561,129)	(529,168)
Total fixed assets, net	370,309	402,270
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	224,473	224,473
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	728,245	728,245
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 0	$ 0

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Dilutive Shares Not Included in Loss Per Share Computation) (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	138,992,936	134,789,603
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	1,277,778	1,477,778
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	129,699,090	125,295,757
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive shares not included in loss per share computation	8,016,068	8,016,068

v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounting Policies [Abstract]
Cash insured amount	$ 250,000
Depreciation expense	31,962	$ 32,064
Shipping and handling costs	$ 6,340	$ 8,355

v3.24.1.1.u2

OPERATING LEASE (Details Narrative) - USD ($)	Mar. 25, 2019	Mar. 31, 2024	Mar. 31, 2023
Operating Lease
Base rent obligation	$ 33,825
Future minimum lease payments		$ 0	$ 0

v3.24.1.1.u2

NOTES PAYABLE (Details Narrative) - USD ($)				3 Months Ended
	Apr. 16, 2021	Apr. 09, 2021	Apr. 02, 2021	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Notes payable				$ 270,000		$ 299,458
Principal payments amount				0
Interest expense				17,034	$ 17,051
Accrued interest				$ 176,664		$ 159,630
Common Stock Warrants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Debt principal amount	$ 25,000	$ 50,000	$ 200,000
Interest rate	18.00%	18.00%	18.00%
Common stock warrants issued	250,000	500,000	2,000,000
Warrants exercise price	$ 0.25	$ 0.20	$ 0.20
Debt instrument, term	5 years	5 years	5 years

v3.24.1.1.u2

NOTES PAYABLE – RELATED PARTY (Details Narrative) - USD ($)																							3 Months Ended
	Mar. 21, 2024	Mar. 06, 2024	Jan. 09, 2024	Dec. 12, 2023	Nov. 02, 2023	Sep. 11, 2023	Jun. 25, 2023	Jun. 05, 2023	May 12, 2023	Apr. 28, 2023	Apr. 12, 2023	Mar. 24, 2023	Mar. 03, 2023	Feb. 24, 2023	Feb. 14, 2023	Sep. 22, 2022	Sep. 09, 2022	Aug. 31, 2022	Aug. 29, 2022	Aug. 22, 2022	Apr. 02, 2022	Apr. 02, 2021	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Apr. 13, 2020	Jan. 16, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Notes payable - related party																							$ 1,828,000		$ 1,750,000
Interest expense																							25,750	$ 23,599
Accrued interest																							$ 1,213,507		$ 996,963
Promissory Note [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Face amount	$ 15,000	$ 40,000	$ 23,000	$ 75,000	$ 100,000	$ 150,000	$ 200,000	$ 100,000	$ 100,000	$ 100,000	$ 150,000	$ 15,000	$ 15,000	$ 50,000	$ 10,000	$ 42,500	$ 60,000	$ 37,000	$ 25,000	$ 20,000
Interest rate	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	20.00%	18.00%	10.00%	10.00%	10.00%	10.00%
Maturity date	Mar. 20, 2025	Mar. 05, 2025	Jan. 08, 2025	Dec. 11, 2024	Nov. 01, 2024	Sep. 10, 2024	Jul. 24, 2024	Jun. 04, 2024	May 11, 2024	Apr. 27, 2024	Apr. 11, 2024	Mar. 23, 2024	Mar. 02, 2024	Feb. 23, 2024	Feb. 13, 2024	Sep. 22, 2024	Aug. 16, 2024	Aug. 31, 2024	Aug. 29, 2024	Aug. 22, 2024
Promissory Note 1 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Face amount						$ 50,000											$ 10,000	$ 13,000	$ 10,000	$ 5,000
Interest rate						20.00%											10.00%	10.00%	10.00%	10.00%
Maturity date						Sep. 10, 2024											Sep. 09, 2024	Aug. 31, 2024	Aug. 29, 2024	Aug. 22, 2024
Promissory Note 2 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Face amount																	$ 10,000
Interest rate																	10.00%
Maturity date																	Sep. 09, 2024
Promissory Note 3 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Face amount																	$ 15,000
Interest rate																	10.00%
Maturity date																	Sep. 09, 2024
Promissory Note 4 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Face amount																	$ 15,000
Interest rate																	10.00%
Maturity date																	Sep. 09, 2024
Michael V Barbera [Member] | Promissory Note [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Face amount																						$ 150,000					$ 50,000
Interest rate																						18.00%				12.00%	10.00%
Maturity date																					Apr. 01, 2024	Oct. 02, 2022
Issuance of shares																						1,500,000
Paul Sallarulo [Member] | Promissory Note [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Face amount																						$ 150,000
Interest rate																						18.00%
Maturity date																					Apr. 01, 2024	Oct. 02, 2022
Issuance of shares																						1,500,000

v3.24.1.1.u2

NOTES PAYABLE – CONVERTIBLE – RELATED PARTY (Details Narrative) - USD ($)					3 Months Ended
	Sep. 15, 2022	May 12, 2021	Feb. 12, 2021	Aug. 03, 2020	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Short-Term Debt [Line Items]
Convertible notes payable, related party					$ 2,144,357		$ 2,144,357
Secured Convertible Promissory Note [Member]
Short-Term Debt [Line Items]
Interest rate	20.00%
Debt principal amount	$ 2,027,695
The original principal	1,689,746
Accrued interest paid	$ 454,612
Convertible Note Payable [Member]
Short-Term Debt [Line Items]
Interest expense					107,218	$ 107,218
Accrued interest					$ 665,430		$ 558,212
Convertible Promissory Note Investors [Member]
Short-Term Debt [Line Items]
Proceeds from convertible debt				$ 1,000,000
Interest rate		20.00%	20.00%	20.00%
Debt principal amount		$ 1,689,746	$ 1,610,005	$ 750,000
Debt Instrument, Term			3 months
The original principal		1,610,005	$ 1,000,000
Accrued interest paid		$ 79,742	$ 110,005
Warrants term		5 years	5 years
Issued to the noteholders		7,500,000	15,000,000
Exercise price		$ 0.35	$ 0.20
Loss on extinguishment		$ 1,874,705	$ 3,686,123

v3.24.1.1.u2

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Liquidated damages	$ 480,000	$ 53,345
Definitive securities purchase agreements, description	the Company entered into definitive securities purchase agreements with 19 accredited investors and issued an aggregate of 19,398,144 shares of common stock, Warrant A to purchase up to an aggregate of 19,398,144 shares of common stock, and Warrant B to purchase up to an aggregate of 19,398,144 shares of Common Stock (for an aggregate of 38,796,288 Warrant Shares), for aggregate gross proceeds to the Company of approximately $5,334,490. Costs of the offering in the amount of $611,603 were charge to additional paid in capital. As of December 31, 2022 the Company also accrued the amount of $386,759 as liquidated damages due to the investors in the Company’s August 2021 private placement, such liquidated damages being related to the Company’s failure to timely file a registration statement on Form S-1 for an underwritten public offering and concurrent listing of the Common Stock on a national exchange.

v3.24.1.1.u2

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock based compensation	$ 15,000	$ 64,226
Common Stock [Member] | Former Chief Executive Officer [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued for cash	1,000,000
Stock based compensation	$ 15,000

v3.24.1.1.u2

OPTIONS AND WARRANTS (Details) - Equity Option [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Offsetting Assets [Line Items]
Outstanding at beginning	1,477,778	1,477,778
Weighted Average Exercise Price, Beginning	$ 0.27	$ 0.27
Aggregate Intrinsic Value, Beginning	$ 0	$ 0
Issued		0
Weighted Average Exercise Price, Issued		$ 0.27
Exercised	0
Weighted Average Exercise Price, Exercised	$ 0.27
Cancelled / Expired	(2,000,000)	0
Weighted Average Exercise Price, Cancelled / Expired	$ 0.27	$ 0.27
Outstanding at ending	1,277,778	1,477,778
Weighted Average Exercise Price, Ending	$ 0.27	$ 0.27
Aggregate Intrinsic Value, Ending	$ 0	$ 0

v3.24.1.1.u2

OPTIONS AND WARRANTS (Details 1) - Equity Option [Member] - $0.01 - $0.50 [Member]	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Offsetting Assets [Line Items]
Range of Exercise Prices, Lower	$ 0.01
Range of Exercise Prices, Upper	$ 0.50
Number Outstanding | shares	1,277,778
Weighted Average Remaining Contractual Life (Years)	2 years 1 month 20 days
Weighted Average Exercise Price	$ 0.27
Average Intrinsic Value | $	$ 0

v3.24.1.1.u2

OPTIONS AND WARRANTS (Details 2) - Warrant [Member] - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding at beginning	125,295,757	139,555,757
Weighted Average Exercise Price, Beginning	$ 0.29	$ 0.29
Aggregate Intrinsic Value, Beginning	$ 135,272	$ 150,667
Warrants granted	4,403,333	2,000,000
Weighted Average Exercise Price, Granted	$ 0.29	$ 0.29
Warrant exercised		0
Weighted Average Exercise Price, Exercised		$ 0.29
Warrant Expired - cancelled		(16,260,000)
Outstanding at ending	129,699,090	125,295,757
Weighted Average Exercise Price, Ending	$ 0.29	$ 0.29
Aggregate Intrinsic Value, Ending	$ 0	$ 135,272

v3.24.1.1.u2

OPTIONS AND WARRANTS (Details 3) - Warrant [Member]	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number Outstanding | shares	129,699,090
Aggregate Intrinsic Value | $	$ 150,667
$0.01 - $0.50 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Range of Exercise Prices, Lower	$ 0.01
Range of Exercise Prices, Upper	$ 0.50
Number Outstanding | shares	129,699,090
Weighted Average Remaining Contractual Life (Years)	2 years 25 days
Weighted Average Exercise Price	$ 0.29
Aggregate Intrinsic Value | $	$ 0
$0.51 - $1.00 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Range of Exercise Prices, Lower	$ 0.51
Range of Exercise Prices, Upper	$ 1.00
Number Outstanding | shares	0
Weighted Average Remaining Contractual Life (Years)	10 months 6 days
Weighted Average Exercise Price	$ 0.60
Aggregate Intrinsic Value | $	$ 0

---